Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company. The Company operates in one reportable segment: the research, manufacture, and distribution of patient-specific, used in the treatment of specific diseases.
$42.11 -4.69 (-10.01%)
As of 03/03/2021 15:59:41 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.